ESMO 2023 Insights: "CheckMate 7FL Phase 3 Study - Nivo or Placebo in Combination With Neoadjuvant Chemo Followed by Adjuvant ET in Patients With High-Risk ER+ HER2- BC"

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

ESMO 2023 Insights: "CheckMate 7FL Phase 3 Study - Nivo or Placebo in Combination With Neoadjuvant Chemo Followed by Adjuvant ET in Patients With High-Risk ER+ HER2- BC"

By ecancer FEATURING Sherene Loi

458 views

October 25, 2023

0 Comments

London Breast Meeting 2024

Wed, Sep 4, 2024

11:31

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Top 5 Abstracts Summary: "SONIA, NATALEE, PHERGain, …

Feat. P. Tarantino

12:35

Insights from 2023 SABCS

SABCS 2023 Summary: "What Is the Appropriate 1L Therapy for ER+…

Feat. S. Tolaney, H. Rugo

28:36

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Summary: "eBC Expert Panel Discussion on Key Trials …

Feat. H. Rugo, K. Jhaveri

03:40

Integrity Continuing Education

SABCS 2023 Insights: "CAPItello-291 Trial - Capivasertib & …

Feat. A. Bardia

17:39

Yale School of Medicine

2023 Menopause Update

Feat. M. Minkin

14:16

Dana-Farber Cancer Institute

Year in Review: Breast Cancer

Feat. P. Tarantino

17:20

Insights from 2023 ESMO Annual Meeting

ESMO 2023 Summary: "Top 5 Breast Cancer Studies Including KEYNO…

Feat. P. Tarantino

09:19

Insights from 2023 SABCS

SABCS 2023 Insights: "Biology or Stage? Tailoring Treatment for…

Feat. K. Kalinsky

57:44

Vogl, NY

Vogl,NY on How to Ask Good Questions at Medical Meetings

Feat. S. Vogl

11:28

Insights from 2023 SABCS

SABCS 2023 Insights: "ctDNA Monitoring of ER+/HER2- High Risk B…

Feat. L. Pusztai

04:28

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "ASCENT-05/OptimICE-RD (AFT-65): Adjuvant …

Feat. S. Tolaney

10:27

Insights from 2023 SABCS

SABCS 2023 Summary: "What Is the Role for CDK 4/6i in the Adjuv…

Feat. S. Tolaney, H. Rugo

49:07

SABCS 2022 Conference Coverage

SABCS 2022 Expert Panel Discussion: Practice-Changing Updates

Feat. J. O'Shaughnessy, S. Tolaney, S. Hurvitz, H. Rugo

05:43

Total Health

Neoadjuvant Chemo for HR+ BC: Year in Review

Feat. C. Ma

22:34

Dana-Farber Cancer Institute

What's New in Breast Cancer?

Feat. S. Tolaney

50:59

Insights from 2023 ESMO Annual Meeting

ESMO 2023 Panel Discussion: "Early Stage Breast Cancer"

Feat. S. Tolaney, H. Rugo

17:35

Insights from 2023 SABCS

SABCS 2023 Summary: "Top 5 Studies Including KATHERINE & HE…

Feat. P. Tarantino

23:58

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Summary: "mBC Expert Panel Discussion on Key Trials …

Feat. H. Rugo, K. Jhaveri

27:04

Fengting Yan

Cancer Screening Molecular Tools

07:18

V.K. Gadi

Login

Login

Join VuMedi

ESMO 2023 Insights: "CheckMate 7FL Phase 3 Study - Nivo or Placebo in Combination With Neoadjuvant Chemo Followed by Adjuvant ET in Patients With High-Risk ER+ HER2- BC"

Related Content